Sign up to save your podcasts
Or
Share An Analysis From the SELECT Trial - COVID-19| ESC 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
An Analysis From the SELECT Trial - COVID-19| ESC 2024
Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disease.
View all episodes
By American College of Cardiology
4.2
162162 ratings
Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disease.
More shows like JACC This Week
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
This Week in Cardiology
906 Listeners
JACC Specialty Journals
21 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
65 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
437 Listeners